• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

N Engl J Med. Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011

Giuseppe

Emeritus
[Source: The New England Journal of Medicine, full text: (LINK). Abstract, edited.]

Original Article

Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011


Robyn Neblett Fanfair, M.D., M.P.H., Kaitlin Benedict, M.P.H., John Bos, M.P.H., Sarah D. Bennett, M.D., M.P.H., Yi-Chun Lo, M.D., Tolu Adebanjo, M.D., M.P.H., Kizee Etienne, M.P.H., Eszter Deak, Ph.D., M.P.H., Gordana Derado, Ph.D., Wun-Ju Shieh, M.D., Ph.D., M.P.H., Clifton Drew, D.V.M., Ph.D., Sherif Zaki, M.D., Ph.D., David Sugerman, M.D., M.P.H., Lalitha Gade, M.Pharm., Elizabeth H. Thompson, B.S., Deanna A. Sutton, Ph.D., David M. Engelthaler, M.S., James M. Schupp, M.B.A., Mary E. Brandt, Ph.D., Julie R. Harris, Ph.D., M.P.H., Shawn R. Lockhart, Ph.D., George Turabelidze, M.D., and Benjamin J. Park, M.D.

N Engl J Med 2012; 367:2214-2225 - December 6, 2012 - DOI: 10.1056/NEJMoa1204781



Background

Mucormycosis is a fungal infection caused by environmentally acquired molds. We investigated a cluster of cases of cutaneous mucormycosis among persons injured during the May 22, 2011, tornado in Joplin, Missouri.


Methods

We defined a case as a soft-tissue infection in a person injured during the tornado, with evidence of a mucormycete on culture or immunohistochemical testing plus DNA sequencing. We conducted a case?control study by reviewing medical records and conducting interviews with case patients and hospitalized controls. DNA sequencing and whole-genome sequencing were performed on clinical specimens to identify species and assess strain-level differences, respectively.


Results

A total of 13 case patients were identified, 5 of whom (38%) died. The patients had a median of 5 wounds (range, 1 to 7); 11 patients (85%) had at least one fracture, 9 (69%) had blunt trauma, and 5 (38%) had penetrating trauma. All case patients had been located in the zone that sustained the most severe damage during the tornado. On multivariate analysis, infection was associated with penetrating trauma (adjusted odds ratio for case patients vs. controls, 8.8; 95% confidence interval [CI], 1.1 to 69.2) and an increased number of wounds (adjusted odds ratio, 2.0 for each additional wound; 95% CI, 1.2 to 3.2). Sequencing of the D1?D2 region of the 28S ribosomal DNA yielded Apophysomyces trapeziformis in all 13 case patients. Whole-genome sequencing showed that the apophysomyces isolates were four separate strains.


Conclusions

We report a cluster of cases of cutaneous mucormycosis among Joplin tornado survivors that were associated with substantial morbidity and mortality. Increased awareness of fungi as a cause of necrotizing soft-tissue infections after a natural disaster is warranted.



The views expressed in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.



Source Information

From the Mycotic Diseases Branch (R.N.F., K.B., S.D.B., T.A., K.E., E.D., L.G., M.E.B., J.R.H., S.R.L., B.J.P.) and Biostatistics Office (G.D.), Division of Foodborne, Waterborne, and Environmental Diseases; the Epidemic Intelligence Service, Office of Workforce and Career Development (R.N.F., S.D.B., Y.-C.L.); the Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology (W.-J.S., C.D., S.Z.); and the Division of Injury Response (D.S.), Centers for Disease Control and Prevention, Atlanta; the Missouri Department of Health and Senior Services, Jefferson City (J.B., Y.-C.L., G.T.); the University of Texas Health Science Center, San Antonio (E.H.T., D.A.S.); and the Translational Genomics Research Institute, Flagstaff, AZ (D.M.E., J.M.S.).

Address reprint requests to Dr. Park at 1600 Clifton Rd., MS C-09, Atlanta, GA 30333, or at bpark1@cdc.gov.
-
-------
 
Back
Top Bottom